Vita 34 AG
V3V | F
Overview
Corporate Details
- ISIN(s):
- DE000A0BL849
- LEI:
- 529900OEWA4GSZEZ4P40
- Country:
- Germany
- Address:
- Perlickstr. 5, 04103 Leipzig
- Website:
- https://www.vita34.de/en/
- Sector:
- Health Care
- Industry:
- Health Care Providers & Services
Description
Vita 34 was founded in Leipzig in 1997 and is today one of the leading cell banks in Europe. As the first private umbilical cord blood bank in Europe and a pioneer in cell banking, the company has since then been a complete provider of cryopreservation services for the collection, processing and storage of stem cells from umbilical cord blood and umbilical cord tissue. Based on the expansion of the business model in 2019, Vita 34 intends to also offer the storage of immune cells from peripheral blood as well as of stem cells from endogenous fat in the future. Endogenous cells are a valuable source of medical cell therapy and are kept alive at temperatures as low as minus 200 degrees Celsius to be used as part of a treatment when needed.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-10 00:00 |
Annual Audited Financial Statements
Jahresabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
|
German | 348.2 KB | |
| 2025-05-29 16:19 |
Takeover Announcement Report
FamiCord AG acquires majority stake in Narodni Centrum Pupecnikove Krve and Rod…
|
English | 6.6 KB | |
| 2025-05-28 07:00 |
Earnings Release
FamiCord AG starts 2025 financial year with accelerated growth and increases pr…
|
English | 16.6 KB | |
| 2025-05-28 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2025
|
English | 675.0 KB | |
| 2025-05-19 00:00 |
Annual Report
Konzernabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
|
German | 1.6 MB | |
| 2025-05-15 15:05 |
General Meeting Notice
FamiCord AG: Bekanntmachung der Einberufung zur Hauptversammlung am 25.06.2025 …
|
German | 88.4 KB | |
| 2025-04-30 14:09 |
Earnings Release
FamiCord AG continues growth course in 2024 after strong year-end business and …
|
English | 18.6 KB | |
| 2025-04-30 00:00 |
Annual Report
Annual financial report 2024
|
English | 6.9 MB | |
| 2025-04-23 16:18 |
Report Publication Announcement
|
English | 4.4 KB | |
| 2025-04-23 00:00 |
Report Publication Announcement
Hinweis auf Jahresfinanzbericht vom 01.01.2024 bis zum 31.12.2024
|
German | 5.7 KB | |
| 2025-04-23 00:00 |
Report Publication Announcement
Hinweis auf Konzernabschluss vom 01.01.2024 bis zum 31.12.2024
|
German | 5.7 KB | |
| 2025-04-23 00:00 |
Report Publication Announcement
Hinweis auf Jahresfinanzbericht vom 01.01.2024 bis zum 31.12.2024
|
German | 5.7 KB | |
| 2025-04-23 00:00 |
Report Publication Announcement
Hinweis auf Konzernabschluss vom 01.01.2024 bis zum 31.12.2024
|
German | 5.7 KB | |
| 2025-04-10 17:35 |
Earnings Release
FamiCord AG significantly exceeds annual earnings guidance for 2024 on the basi…
|
English | 6.5 KB | |
| 2025-02-06 07:30 |
Regulatory News Service
Vita 34 AG strengthens its international brand presence by change of name to Fa…
|
English | 8.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-12-11 | AOC Health GmbH | Close relation | Other | None | 6,572,680.40 EUR |
| 2023-12-11 | Baran, Jakub Julian | Other | Buy | None | 99,998.80 EUR |
| 2022-09-28 | Dr. Granderath, Rat und Vermögen GmbH | Close relation | Buy | None | 21,557.28 EUR |
| 2022-06-02 | Dr. Granderath, Rat und Vermögen GmbH | Close relation | Buy | None | 33,000.00 EUR |
| 2022-06-02 | Schweppe, Thomas | Supervisory board | Other | None | N/A |
| 2021-11-18 | Lorenzen, Hans-Jochen | Supervisory board | Sell | None | 180,625.00 EUR |
| 2021-11-10 | Project Mill Gesellschaft für interdisziplinären Know-how-Transfer GmbH | Close relation | Other | None | 36,146.25 EUR |
| 2021-11-09 | Zeitfracht GmbH & Co. KGaA | Close relation | Sell | None | 35,525.00 EUR |
| 2021-11-09 | von Blücher, Dietmar | Board | Buy | None | 28,820.00 EUR |
| 2021-11-09 | von Blücher, Dietmar | Board | Buy | None | 14,400.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ANGLING DIRECT PLC | United Kingdom | ANG | |
|
ANGLO ASIAN MINING PLC | Azerbaijan | AAZ | |
|
Athens Medical C.S.A. | Greece | IATR | |
|
Bastide Le Confort Médical | France | BLC | |
|
Biocartis Group NV | Belgium | BCART | |
|
Braster S.A. | Poland | BRA | |
|
Cannabis Poland Spolka Akcyjna | Poland | CBD | |
|
Carasent | Norway | CARA | |
|
Center for Genetics and Reproductive Medicine "GENETICO" | Russian Federation | GECO | |
|
Clinica Baviera S.A. | Spain | CBAV |